 His adeptness at physical organic chemistry enabled him to understand the individual H2-receptor antagonist drugs they developed.Initially, the team developed burimamide as a potential H2-receptor antagonist for medicinal use.However, it was soon realised that burimamide was not an appropriate oral medicine.